Sensation Disorders
24
7
10
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
1 terminated out of 24 trials
88.9%
+2.4% vs benchmark
8%
2 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (24)
The Effect of Cycle Ergometer With Biofeedback on Deep Sensation in Elderly Patients With Knee Osteoarthritis
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Long Term Outcomes After Vestibular Implantation
Multichannel Vestibular Implant Early Feasibility Study
The Effects of Chiropractic Care in Children With Parent-reported Sensory Processing Disorder
Upper Extremity Sensation and Function in Children With Cerebral Palsy
Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
Vestibular Implantation in Older Adults
Photobiomodulation on Neuropathic Pain and Sensation Post-mastectomy
GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
Effects of an Online Hearing Support for First-time Hearing Aid Users
Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients
Extension Study to Study PQ-110-001 (NCT03140969)
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis
Investigation of an Updated Bone-anchored Sound Processor
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
Acupuncture for CIPN in Breast Cancer Patients